Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Cell Therapy Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market for cell therapy has witnessed substantial growth in recent years. The size of the market is projected to surge from $14.56 billion in 2024, and reach a value of $16.87 billion in 2025, with a compound annual growth rate (CAGR) of 15.8%. This past period of growth is due largely to early exploration and discoveries, regulatory milestones, clinical experiments and research, the willingness of early adopters and innovative corporations to implement the technology, and favorable market acceptance and perception.

The market size of cell therapy is projected to witness a swift expansion in the coming years, with an estimated rise to $28.67 billion in 2029, featuring a compound annual growth rate (CAGR) of 14.2%. The forecast period’s growth may be due to ethical and societal considerations, investment and funding patterns, consumer or patient demand, healthcare infrastructure, and fast innovation cycles. Key trends during the forecast period encompass personalized medicine, burgeoning targeted treatments, gene editing technologies, an extension in stem cell research, advancements in immunotherapy, and manipulation of the microenvironment.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Cell Therapy Market?

The cell therapy market is growing due to the increasing incidence of chronic diseases. Chronic diseases, as defined by the US Centers for Disease Control and Prevention (CDC), are conditions that persist for a year or more and require medical attention, limit daily activities, or both. These ailments include heart disease, cancer, diabetes, and Parkinson’s disease. Patients with spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis can potentially derive advantages from stem cells. In July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency in the US, issued considerable revise on public health strategies. Heart disease or stroke kill over 944,800 Americans annually, representing more than one-third of all deaths. Furthermore, cancer is diagnosed in 1.7 million individuals in the U.S. every year, with over 600,000 succumbing to the ailment, which is the second top cause of death. Over 38 million Americans are affected by diabetes, with an additional 98 million adults being prediabetic, raising the chance for type 2 diabetes. Diabetes can cause serious complications such as heart disease, kidney failure, and loss of vision. Obesity affects 20% of kids and 42% of adults, thereby increasing the risk of chronic diseases like type 2 diabetes, heart disease, and specific cancers. The increasing prevalence of chronic diseases escalated the necessity for cell therapies, contributing to the cell therapy market’s expansion.

Which Primary Segments of the Cell Therapy Market Are Driving Growth and Industry Transformations?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Cell Therapy Market?# Market?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Cell Therapy Market?

Top industry contenders are tactically forging partnerships and collaborations to widen their product range and enhance their geographic footprint. In November 2023, Ajinomoto Co Inc., a Japanese food corporation, purchased Forge Biologics for a whopping $620 million. This acquisition is intended to strengthen Ajinomoto Co Inc.’s worldwide abilities in AAV and plasmid gene therapy production, further enriching and enhancing its current contract development and manufacturing services. Forge Biologics, a biotech company based in the US, is committed to the development of cell therapy technologies for the treatment of a variety of diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What Parameters Are Used to Define the Cell Therapy Market?

Cell therapy refers to the replacement or repair of damaged tissue and/or cells through the transplantation of human cells. Numerous different types of cells may be used as part of a therapy or treatment for a number of diseases and disorders with the help of new technologies, inventive products, and infinite imagination. It is a form of treatment wherein a patient receives live cells via injection, grafting, or implant in order to produce a therapeutic result.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model